Treatment of pyoderma gangrenosum with mycophenolate mofetil as a steroid-sparing agent.
Background: Mycophenolate mofetil (MMF) has enjoyed increasing popularity as an emerging immunosuppressant treatment for various autoimmune dermatologic conditions, including pyoderma gangrenosum (PG).Objective: The aim of this study was to examine the efficacy and safety of MMF as used in PG.Method...
| Published in: | Journal of the American Academy of Dermatology Vol. 69; no. 4; pp. 565 - 570 |
|---|---|
| Main Authors: | , |
| Format: | research Journal Article |
| Published: |
Elsevier B.V.
Oct2013
|
| Online Access: | View this record in EBSCOhost |